Designing biologic selectivity for inflammatory bowel disease – role of vedolizumab

by Krupka N, Baumgart DC
Published 2014-12-01

Oral versus intravenous iron therapy in patients with inflammatory bowel disease and iron deficiency with and without anemia in Germany – a real-world evidence analysis

by Stein J, Haas JS, Ong SH, Borchert K, Hardt T, Lechat E, Nip K, Foerster D, Braun S, Baumgart DC
Published 2018-02-01